IONS vs VERO · rev $514.0M vs rev $64.8M
Ionis Pharmaceuticals Inc (IONS) versus Venus Concept Inc (VERO) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Venus Concept Inc (VERO) is a medical devices company listed on NASDAQ.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported VERO revenue for 2024-12-31 was $64.8M. Net income was -$47.0M. Revenue was down 15.1% from 2023-12-31 to 2024-12-31. VERO currently screens at market cap $578.2K.
IONS currently screens at market cap $12.28B. VERO currently screens at market cap $578.2K.
Not investment advice. Open the IONS and VERO stock pages for the full models.
Not investment advice.